Related Experiment Video

Updated: Aug 6, 2026

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence
04:56

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence

Published on: December 30, 2025

Ad-fRNK and Ad-p53 cooperate to augment drug-induced death of a transformed cell line

Lori Kornberg1

  • 1Department of Otolaryngology, University of Florida, Gainesville, FL 32610, USA. kornblj@ent.ufl.edu

Anticancer Research
|August 5, 2006
PubMed
Abstract

Insights

Combining wild-type p53 with a focal adhesion kinase inhibitor (FRNK) enhances cancer cell apoptosis and drug sensitivity. This combined therapy, targeting key survival pathways, offers a promising strategy for overcoming drug resistance in cancer treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Cancer cells exhibit drug resistance due to dysregulated survival pathways, including p53 mutations and elevated focal adhesion kinase (FAK) expression.
  • FAK influences cell survival through both p53-dependent and -independent mechanisms.

Purpose of the Study:

  • To investigate the potential of combined therapy using wild-type p53 and a FAK inhibitor (FRNK) to sensitize cancer cells to anticancer drugs.
  • To evaluate the impact of co-expressing p53 and FRNK on cancer cell viability, apoptosis, and drug response.

Main Methods:

  • RPMI 2650 cells were infected with recombinant adenoviruses to overexpress p53 (Ad-p53) and FRNK (Ad-FRNK).
  • Cell viability and apoptosis were assessed using in vitro assays.
  • Protein expression levels were analyzed via Western blotting.

Main Results:

  • Co-expression of Ad-p53 and Ad-FRNK significantly increased cellular apoptosis compared to individual treatments.
  • Combined Ad-FRNK and Ad-p53 transfection enhanced the cytotoxic effect of four common anticancer drugs.
  • The observed sensitization was linked to the downregulation of endogenous FAK protein.

Conclusions:

  • Combined therapy with wild-type p53 and FRNK effectively sensitizes cancer cells to anticancer drugs.
  • This approach enhances apoptosis and overcomes drug resistance by targeting FAK signaling.
  • The findings support the development of novel therapeutic strategies combining p53 restoration with FAK inhibition.

More Related Videos

Yeast As a Chassis for Developing Functional Assays to Study Human P5314:57

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

Comprehensive Analysis of Drug Response using the FLICK Assay09:42

Comprehensive Analysis of Drug Response using the FLICK Assay

Published on: June 6, 2025

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...